This article may have been created or edited in return for undisclosed payments, a violation of Wikipedia's terms of use. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. (September 2021)

A kinetic exclusion assay (KinExA) is a type of bioassay in which a solution containing receptor, ligand, and receptor-ligand complex is briefly exposed to additional ligand immobilized on a solid phase.^[1][2]

During the assay, a fraction of the free receptor is captured by the solid phase ligand and subsequently labeled with a fluorescent secondary molecule (Figure 1).^[1][2] The short contact time with the solid phase does not allow significant dissociation of the pre-formed complexes in the solution.^[3] Solution dissociation is thus “kinetically excluded” from contributing to the captured receptor and the resulting signal provides a measure of the free receptor in the solution.

Measuring the free receptor as a function of total ligand in a series of equilibrated solutions enables calculation of the equilibrium dissociation constant (K_d).^{[1][2][3][4][5][6][7][8]} Measuring the free receptor with several points before equilibrium enables measurement of the association rate constant (k_on). The off rate (k_off) can also be directly measured, however it is usually calculated from the measured K_d and measured k_on, (k_off = K_d * k_on).

Kinetic exclusion assays have been used to measure K_d’s in the nanomolar to femtomolar range.^{[4][5][6][7][9][10]}

Because the fluorescent secondary molecule is applied after capture of the free receptor from solution (Figure 2) the binding constants measured using a kinetic exclusion assay are for unmodified molecules in solution and thus more accurately reflects endogenous binding interactions than methods requiring modification (typically labeling or immobilization) before measurement.^[1][2] Kinetic exclusion assays have been performed using unpurified molecules,^[4][5] in serum,^[7] and have measured binding to cell membrane proteins on intact whole cell^[8][11] which brings the measured binding interactions closer to their endogenous state.

Molecules suited for measurement by KinExA are antibodies,^{[4][7][12][13][14]} recombinant proteins,^[15][16][17] small molecules,^{[6][18][19][20]} aptamers,^[21][22] lipids,^[23][24] nanobodies,^[25] and toxins.^[12][26][27]

Kinetic exclusion assay have also been applied for concentration immunoassay, where it has proven capable of providing the maximum theoretical, K_d limited, sensitivity.^[28][29] An example of this technique has been employed for sensitive detection of environmental contaminants in near real-time.^[30]

A series of samples are prepared with all the same receptor (R) concentration but in which the ligand (L) concentration is titrated. After equilibrium is reached each sample is measured by flowing it through the column (Figure 2).

For 1:1 reversible binding Equilibrium Kd is defined as

(1) K_d≡k_off/k_on =R*L/RL

the binding is reversible so conservation of mass can be written as

(2) R_T = R+RL

(3) L_T = L +RL

Where:

K_d = equilibrium dissociation constant

k_on = forward rate constant

k_off = reverse rate constant

R = free receptor site concentration at equilibrium

L = free ligand site concentration at equilibrium

RL = concentration of complex at equilibrium

R_T= total concentration of receptors

L_T = total concentration of ligand

A simple equation^[1][2] relating the free fraction of R (=R/R_T) to the K_d and L_T is then fit to the measured data to find the K_d of the interaction.

To measure the rate constants, known concentrations of receptor and ligand are mixed in solution and the quantity of free receptor is repeatedly measured over time as the solution phase reaction occurs. The time course of the free receptor depletion is then fit with a standard bimolecular rate equation.

(4) dLR/dt = k_on∙R∙L - K_d∙k_on∙RL

where K_d * k_on has been substituted for k_off .